These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 37371605

  • 1. DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40+ Cells in Experimental Autoimmune Encephalomyelitis Model in SJL/J Mice.
    Alghibiwi H, Ansari MA, Nadeem A, Algonaiah MA, Attia SM, Bakheet SA, Albekairi TH, Almudimeegh S, Alhamed AS, Shahid M, Alwetaid MY, Alassmrry YA, Ahmad SF.
    Biomedicines; 2023 May 23; 11(6):. PubMed ID: 37371605
    [Abstract] [Full Text] [Related]

  • 2. Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL/J mice through the inhibition of nuclear factor-kappa B signaling in B cells.
    Alomar HA, Nadeem A, Ansari MA, Attia SM, Bakheet SA, Al-Mazroua HA, Alhazzani K, Assiri MA, Alqinyah M, Almudimeegh S, Ahmad SF.
    Brain Res Bull; 2023 Mar 23; 194():45-53. PubMed ID: 36646144
    [Abstract] [Full Text] [Related]

  • 3. CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.
    Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Shahid M, Al-Mazroua HA, As Sobeai HM, Alasmari AF, Alanazi MM, Alhamed AS, Aldossari AA, Attia SM.
    Cell Immunol; 2022 Sep 23; 379():104580. PubMed ID: 35872534
    [Abstract] [Full Text] [Related]

  • 4. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
    Alomar HA, Ansari MA, Nadeem A, Attia SM, Bakheet SA, Al-Mazroua HA, Hussein MH, Alqarni SA, Ahmad SF.
    J Neuroimmunol; 2023 Apr 15; 377():578069. PubMed ID: 36931207
    [Abstract] [Full Text] [Related]

  • 5. Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model.
    Alsaad AMS, Ansari MA, Nadeem A, Attia SM, Bakheet SA, Alomar HA, Ahmad SF.
    Int J Mol Sci; 2023 Aug 20; 24(16):. PubMed ID: 37629172
    [Abstract] [Full Text] [Related]

  • 6. Methylmercury chloride exposure aggravates proinflammatory mediators and Notch-1 signaling in CD14+ and CD40+ cells and is associated with imbalance of neuroimmune function in BTBR T+ Itpr3tf/J mice.
    Ahmad SF, Bakheet SA, Ansari MA, Nadeem A, Alobaidi AF, Attia SM, Alhamed AS, Aldossari AA, Mahmoud MA.
    Neurotoxicology; 2021 Jan 20; 82():9-17. PubMed ID: 33166615
    [Abstract] [Full Text] [Related]

  • 7. Rituximab exerts its anti-arthritic effects via inhibiting NF-κB/GM-CSF/iNOS signaling in B cells in a mouse model of collagen-induced arthritis.
    Ansari MA, Nadeem A, Attia SM, Bakheet SA, Alasmari AF, Alomar HA, Al-Mazroua HA, Alhamed AS, Shahid M, Alqinyah M, Assiri MA, Al-Hamamah MA, Alassmrry YA, Ahmad SF.
    Heliyon; 2023 Jun 20; 9(6):e16673. PubMed ID: 37274671
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice.
    Wang J, He L, Wang S, Zhao H, Chen J, Dong Y, Yasen S, Wang L, Zou H.
    J Ethnopharmacol; 2023 Oct 28; 315():116681. PubMed ID: 37230280
    [Abstract] [Full Text] [Related]

  • 9. CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis.
    Ansari MA, Nadeem A, Attia SM, Bakheet SA, Shahid M, Rehman MU, Alanazi MM, Alhamed AS, Ibrahim KE, Albekairi NA, Ahmad SF.
    Immunobiology; 2022 Sep 28; 227(5):152245. PubMed ID: 35868215
    [Abstract] [Full Text] [Related]

  • 10. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T+ Itpr3tf/J mice.
    Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alotaibi MR, Alasmari AF, Alshammari MA, Al-Mazroua HA, Attia SM.
    Eur J Pharmacol; 2019 Mar 05; 846():100-108. PubMed ID: 30658114
    [Abstract] [Full Text] [Related]

  • 11. Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis.
    Nadeem A, Ahmad SF, Al-Harbi NO, Sarawi W, Attia SM, Alanazi WA, Ibrahim KE, Alsanea S, Alqarni SA, Alfardan AS, Bakheet SA.
    Int Immunopharmacol; 2022 Jun 05; 107():108703. PubMed ID: 35306283
    [Abstract] [Full Text] [Related]

  • 12. Aflatoxin B1 exposure deteriorates immune abnormalities in a BTBR T+ Itpr3tf/J mouse model of autism by increasing inflammatory mediators' production in CD19-expressing cells.
    Almanaa TN, Alwetaid MY, Bakheet SA, Attia SM, Ansari MA, Nadeem A, Ahmad SF.
    J Neuroimmunol; 2024 Jun 15; 391():578365. PubMed ID: 38723577
    [Abstract] [Full Text] [Related]

  • 13. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex.
    Kizelsztein P, Komarnytsky S, Raskin I.
    J Neuroimmunol; 2009 Dec 10; 217(1-2):28-37. PubMed ID: 19796825
    [Abstract] [Full Text] [Related]

  • 14. Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
    Lang Y, Chu F, Liu L, Zheng C, Li C, Shen D, Liu S, Zhang W, Cui L, Zhu J.
    Clin Exp Immunol; 2022 May 12; 207(3):378-386. PubMed ID: 35553640
    [Abstract] [Full Text] [Related]

  • 15. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D, Qiao L, Fu T.
    Biomed Pharmacother; 2020 May 12; 125():109528. PubMed ID: 32106388
    [Abstract] [Full Text] [Related]

  • 16. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M, Shu Y, Yang Y, Zheng X, Li R, Wang Y, Dai Y, Qiu W, Lu Z, Hu X.
    Neurochem Int; 2014 Jan 12; 64():64-72. PubMed ID: 24274996
    [Abstract] [Full Text] [Related]

  • 17. Mdivi-1 Modulates Macrophage/Microglial Polarization in Mice with EAE via the Inhibition of the TLR2/4-GSK3β-NF-κB Inflammatory Signaling Axis.
    Liu X, Zhang X, Niu X, Zhang P, Wang Q, Xue X, Song G, Yu J, Xi G, Song L, Li Y, Ma C.
    Mol Neurobiol; 2022 Jan 12; 59(1):1-16. PubMed ID: 34618332
    [Abstract] [Full Text] [Related]

  • 18. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW.
    Mol Neurobiol; 2018 Apr 12; 55(4):3007-3020. PubMed ID: 28456941
    [Abstract] [Full Text] [Related]

  • 19. Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli.
    Kim JM, Oh YK, Lee JH, Im DY, Kim YJ, Youn J, Lee CH, Son H, Lee YS, Park JY, Choi IH.
    Clin Exp Immunol; 2005 Jun 12; 140(3):450-60. PubMed ID: 15932506
    [Abstract] [Full Text] [Related]

  • 20. Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2/HO-1 and TLR4/NF-κB signaling.
    Khan A, Shal B, Khan AU, Bibi T, Islam SU, Baig MW, Haq IU, Ali H, Ahmad S, Khan S.
    Neurochem Int; 2021 Dec 12; 151():105211. PubMed ID: 34688804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.